IRIS
BRAVACCINI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 931
NA - Nord America 778
EU - Europa 687
SA - Sud America 298
AF - Africa 15
OC - Oceania 2
Totale 2.711
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 747
SG - Singapore 422
HK - Hong Kong 383
IE - Irlanda 311
BR - Brasile 280
DE - Germania 88
IT - Italia 84
TR - Turchia 51
FR - Francia 38
NL - Olanda 32
GB - Regno Unito 28
FI - Finlandia 25
RU - Federazione Russa 20
CA - Canada 17
IN - India 17
BD - Bangladesh 13
MX - Messico 13
AT - Austria 12
IQ - Iraq 10
LT - Lituania 9
VN - Vietnam 8
PL - Polonia 7
AR - Argentina 6
BE - Belgio 6
CZ - Repubblica Ceca 6
ES - Italia 6
UZ - Uzbekistan 6
CN - Cina 5
TN - Tunisia 5
ZA - Sudafrica 5
CO - Colombia 4
SA - Arabia Saudita 4
SE - Svezia 4
VE - Venezuela 4
JP - Giappone 3
UA - Ucraina 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
EC - Ecuador 2
KG - Kirghizistan 2
RS - Serbia 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CH - Svizzera 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
MA - Marocco 1
PK - Pakistan 1
PY - Paraguay 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 2.711
Salva come PNG Salva come JPEG
Città #
Hong Kong 381
Dublin 311
Singapore 195
Santa Clara 136
Boardman 130
Dallas 112
The Dalles 88
Istanbul 43
Munich 38
Assago 32
Ashburn 27
São Paulo 26
Amsterdam 23
Helsinki 22
Los Angeles 17
Frankfurt am Main 16
Chicago 10
Milan 10
Boston 9
Düsseldorf 9
San Francisco 9
Vienna 9
Belo Horizonte 8
Brasília 8
New York 8
Rio de Janeiro 7
Brno 6
Brooklyn 6
Brussels 6
Mexico City 6
Montreal 6
Paris 6
Toronto 6
Atlanta 5
Bexley 5
Campinas 5
Lugo 5
Tashkent 5
Warsaw 5
Ankara 4
Guarulhos 4
Juiz de Fora 4
New Delhi 4
Nuremberg 4
Ottawa 4
Porto Alegre 4
Rome 4
Stockholm 4
Betim 3
Birmingham 3
Bogotá 3
Houston 3
Lauterbourg 3
Limeira 3
London 3
Manchester 3
Maricá 3
Milwaukee 3
Palhoça 3
Pescara 3
Portsmouth 3
Ribeirão Preto 3
Riyadh 3
Santo André 3
São Sebastião do Paraíso 3
Tokyo 3
Turku 3
Viamão 3
Virginia Beach 3
Americana 2
Apodi 2
Atibaia 2
Avaré 2
Baku 2
Basra 2
Belgrade 2
Bishkek 2
Cape Town 2
Caxias do Sul 2
Charlotte 2
Chennai 2
Contagem 2
Curitiba 2
Dakar 2
Denver 2
Garanhuns 2
Ho Chi Minh City 2
Hortolândia 2
Itajubá 2
Itapema 2
Itaquaquecetuba 2
Johannesburg 2
João Pessoa 2
Lecce 2
Misilmeri 2
Nova Iguaçu 2
Osasco 2
Pacajus 2
Phoenix 2
Ponsacco 2
Totale 1.917
Salva come PNG Salva come JPEG
Nome #
Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients? 72
The use of platelets as a clinical tool in oncology: opportunities and challenges 48
Biomarkers: which ones do we really need today? 43
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study 35
Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiota 35
Re: Clinicopathological features and outcomes comparing patients with invasive ductal and lobular breast cancer 35
Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter 33
Urinary Biomarkers in Tumors: An Overview 32
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension 31
Evaluating the appropriateness of chemotherapy in a low-resource cancer centre in sub-Saharan Africa 30
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer 30
Androgen receptor signaling pathways as a target for breast cancer treatment 30
A functional survey of the regulatory landscape of estrogen-receptor-positive breast cancer evolution 30
TMB in NSCLC: A Broken Dream? 29
Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS-CoV-2 in Exposed Individuals From Emilia Romagna Region and COVID-19 Severity 29
Safety and efficacy of anti-PD-1 inhibitors in Chinese patients with advanced lung cancer and hepatitis B virus infection: a retrospective single-center study 29
A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors 29
Ki67 and PR in patients treated with CDK4/6 Inhibitors: A real-world experience 28
Are we ready to use TMB in breast cancer clinical practice? 27
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer? 27
Are Androgen and Estrogen Receptors in DCIS Patients Prognostic Indicators of Relapse Independently of Treatment? 27
An H-1 NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia 27
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial 26
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer 26
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in patients with different subtypes of breast cancer 26
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population? 26
Telomerase Activity Analysis In Urine Sediment for Bladder Cancer 26
Expanding the Horizon of Multidisciplinarity: Incorporating Biomechanical, Metabolic, and Functional Factors Into Registry-Based Research to Predict Subsequent Risk for Total Knee Arthroplasty 25
An initiative to assess the quality of Tanzanian cervical cancer specimens for HPV and telomerase detection 25
Usefulness of immunological detection of the human telomerase reverse transcriptase 25
Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer 25
Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer? 24
Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study 24
What Influences the Choice of Ibrutinib-Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia? 24
Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients 24
Urinary biomarkers of nonmuscle-invasive bladder cancer: current status and future potential 24
Relevance of urine telomerase in the diagnosis of bladder cancer 24
Androgen receptor in breast cancer: The "5W" questions 24
Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells 23
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy 23
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement 23
Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance 23
Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma insitu treated with surgery and radiotherapy 23
Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer 23
TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancer 23
Frequency of actionable alterations in epidermal growth factor receptor (EGFR) wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR) 22
Setting Up a Medical Oncology Educational Program in Sub-Saharan Africa 22
NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus 22
Urine telomerase: An important marker in the diagnosis of bladder cancer 22
Expanding Roles of De Novo Lipogenesis in Breast Cancer 22
Combined analysis of miR-200 family and its significance for breast cancer 22
Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitis 22
Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data 22
Why the complications of COVID-19 patients differ in elderly and young cancer patients 22
Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer 21
The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects 21
Significant Advancements and Evolutions in Chimeric Antigen Receptor Design 21
No more disparities among regions in Italy: recent approval of genomic test reimbursability for early breast cancer patients in the country 21
Molecular characterization of cytotoxic and drug resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines 21
International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease. 21
Letter to the Editor discussing: Hacker S, Lenz C, Reichert L, Ringseis R, Zentgraf K, Krüger K. Vitamin D status and its determinants in German elite athletes. Eur J Appl Physiol. 2025 Jan 4. doi: 10.1007/s00421-024–05699-6 20
Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls 20
What to look for in cell-free DNA from breast cancer patients 20
Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancer 20
International consensus on severe lung cancer-the first edition 20
Frequency of Actionable Alterations in EGFR wt NSCLC: Experience of the Wide Catchment Area of Romagna (AVR) 20
Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients 20
ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA 20
CAR T cells targeting options in the fight against multiple myeloma 20
Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold 20
Sorafenib for the treatment of breast cancer 20
Fluorescence In Situ Hybridization in Urine Samples (UroVysion Kit) 20
Spotlight on PSMA as a new theranostic biomarker for bladder cancer 19
In-111-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance 19
The current role of telomerase in the diagnosis of bladder cancer 19
Biofunctional characteristics of in situ and invasive breast carcinoma 19
Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling 19
KRAS mutation predict response and outcome in advanced non-small cell lung carcinoma without driver alterations receiving PD-1 blockade immunotherapy combined with platinum-based chemotherapy: a retrospective cohort study from China 19
Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CIN 19
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 19
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients 19
Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue 18
Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients 18
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy? 18
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy 18
The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study 18
Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer 18
Human papillomavirus E6 alters Toll-like receptor 9 transcripts and chemotherapy responses in breast cancer cells in vitro 18
Epithelial-to-mesenchymal transition and EGFR status in NSCLC: the role of vimentin expression 18
Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer? 18
Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases? 18
Primary epithelioid angiosarcoma of the thyroid: A case report 17
Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer? 17
Re: "Evolution of low HER2 expression between early and advanced-stage breast cancer" 17
Benefit from anthracyclines in relation to biological profiles in early breast cancer 17
Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma 17
Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report 16
Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histology 16
Progress with palbociclib in breast cancer: latest evidence and clinical considerations 16
Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer 16
Totale 2.359
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.667
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024187 0 0 0 0 0 0 0 0 0 0 0 187
2024/20252.496 264 71 193 57 234 318 149 135 304 299 283 189
2025/2026284 284 0 0 0 0 0 0 0 0 0 0 0
Totale 2.967